Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder

Biological Psychiatry

Volumn 49, Issue 4, 2001, Pages 385-388

  Enoch, Mary Anne ^a   Greenberg, Benjamin D ^b   Murphy, Dennis L ^b   Goldman, David ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Gender; Genes; Obsessive compulsive; Receptor; Serotonin

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEX DIFFERENCE;

ADULT; FEMALE; GENOTYPE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEROTONIN; SEX DISTRIBUTION;

EID: 0035865578     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01040-4     Document Type: Article

References (27)

1. Diagnostic issues and epidemiology in obsessive-compulsive disorder
2. Prolactin and cortisol responses to NK-212, a serotonin agonist, in obsessive-compulsive disorder
3. Genetics of obsessive-compulsive disorder
4. Gender differences in obsessive compulsive disorder
5. Genetic and environmental influences on obsessional traits and symptoms
6. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa
7. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A
8. 5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder
9. Obsessive-compulsive disorder in adolescence: An epidemiologic study
10. Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients
11. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers
12. Eating disorder and obsessive-compulsive disorder: Neurochemical and phenomenological commonalities
13. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder
14. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder
15. Patients with anorexia nervosa have elevated scores on the Yale-Brown Obsessive-Compulsive scale
16. Symptoms of obsessive-compulsive disorder
17. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences
18. Evidence for linkage disequilibrium between serotonin transporter gene (SLC6A4) and obsessive compulsive disorder
19. Cortisol response to d-Fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: Evidence for a gender-related effect
20. A family study of obsessive-compulsive disorder
21. A family study of obsessive compulsive disorder
22. Obsessive-compulsive disorder: Symptom overview and epidemiology
23. The genetic basis and neurobiological characteristics of obsessive-compulsive disorder
24. 5-HT2A promoter polymorphism in anorexia nervosa
25. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter
26. The cross-national epidemiology of obsessive-compulsive disorder
27. Characterization of the human 5-HT2A receptor gene promoter